US Dual Listing Webinar for Nordic Life Sciences Companies 2020

With strong and continuing global interest in the life sciences sector, Nasdaq is experiencing high demand from Nordic listed life sciences companies to help them explore a second, or dual, listing in the United States, to complement their existing listing and permit these Nordic-based life sciences companies to tap additional financing sources.

This webinar, co-hosted by Nasdaq Nordics and Advokatfirman Vinge, is designed to address and shed light on some of these key items to enable decision makers to more clearly assess whether a dual listing in the US is an option that should be considered.
C-suite executives and board members of Nordic life sciences companies will find this seminar/webinar especially helpful as they consider the strategic decision potentially to dual list, enabling them to explore with a panel of experts, relevant topics such as marketing, finance and legal, and also to learn first-hand from the practical experiences of executives and other professionals from a Nordic listed life sciences company that has recently gone through this process.

For more information and registration click here.